Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
雷莫芦单抗联合多西他赛对比安慰剂联合多西他赛治疗铂类化疗后局部晚期或转移性尿路上皮癌患者（RANGE）：一项随机、双盲、3期试验的总生存期和最新结果
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(19)30668-0
Petrylak, Daniel P; de Wit, Ronald; Chi, Kim N; Drakaki, Alexandra; Sternberg, Cora N; Nishiyama, Hiroyuki; Castellano, Daniel; Hussain, Syed A; Fléchon, Aude; Bamias, Aristotelis; Yu, Evan Y; van der Heijden, Michiel S; Matsubara, Nobuaki; Alekseev, Boris; Necchi, Andrea; Géczi, Lajos; Ou, Yen-Chuan; Coskun, Hasan Senol; Su, Wen-Pin; Bedke, Jens; Gakis, Georgios; Percent, Ivor J; Lee, Jae-Lyun; Tucci, Marcello; Semenov, Andrey; Laestadius, Fredrik; Peer, Avivit; Tortora, Giampaolo; Safina, Sufia; Garcia Del Muro, Xavier; Rodriguez-Vida, Alejo; Cicin, Irfan; Harputluoglu, Hakan; Tagawa, Scott T; Vaishampayan, Ulka; Aragon-Ching, Jeanny B; Hamid, Oday; Liepa, Astra M; Wijayawardana, Sameera; Russo, Francesca; Walgren, Richard A; Zimmermann, Annamaria H; Hozak, Rebecca R; Bell-McGuinn, Katherine M; Powles, Thomas
